CGT

1,163개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,163 programs
CGTLimited DatastaleGuangzhou JOYO Pharma Co., LtdPhase 1

Second dose group (Gene modified anti-IL1RAP Chimeric Antigen Receptor T Cells :2.5×10^8, Gene modified anti-IL1RAP Chimeric Antigen Receptor T Cells :2.5×10^8(Second dose group))

HCC · HCC

#HCC#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 31Status Recruiting
CGTLimited DatastaleSyndax PharmaceuticalsPhase 1

Midostaurin (Midostaurin)

Acute Myeloid Leukemia; AML, Adult · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 31Status Recruiting
CGTLimited DatastaleThe Faris Foundation USAPhase 1

T cells or CAR T cells (T cells or CAR T cells)

Sarcoma; HER-2 Protein Overexpression · Sarcoma

#Sarcoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 31Status Recruiting
CGTLimited DatastaleFrontiergate Biopharm（Hainan） C…Phase 1

Targeted CAR-T Cells (Targeted CAR-T Cells)

Advanced Solid Cancers · Advanced Solid Cancers

#AdvancedSolidCancers#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 31Status Recruiting
CGTLimited DatastaleKecellitics Biotech Company LtdPhase 2

:Anti-CD22-CAR (:Anti-CD22-CAR)

Leukemia; Lymphoma · CD22

#CD22#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTLimited DatastaleChinese PLA General HospitalPhase 2

Anti-BCMA-CD19 CAR-T cells (Anti-BCMA-CD19 CAR-T cells)

IgG4 Related Disease; B-cell Mediated Autoimmune Disorders · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 30Status Recruiting
CGTLimited DatastaleThe First Affiliated Hospital o…Phase 1

Autologous BCMA CAR-T cells and CD19 CAR-T cells (Autologous BCMA CAR-T cells and CD19 CAR-T cells)

Relapsed or Refractory Multiple Myeloma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 30Status Active
CGTStandard DatabasestaleHebei Senlang Biotechnology Inc…Phase 2

Autologous BCMA-targeting CAR T cells (Autologous BCMA-targeting CAR T cells)

Multiple Myeloma in Relapse; Multiple Myeloma Refractory · BCMA

#BCMA#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Recruiting
CGTLimited DatastaleInstituto de Investigación Hosp…Phase 1

Autologous CD19/CD22 CAR T cells (Autologous CD19/CD22 CAR T cells)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 30Status Recruiting
CGTLimited DatastaleKara Lynn DavisPhase 1

Autologous CD22 CAR T (Autologous CD22 CAR T)

B Cell Lymphoma; Acute Lymphoblastic Leukemia, Pediatric · CD22

#CD22#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 30Status Active
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 1

BCMA-CART cells (BCMA-CART cells)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 30Status Active
CGTLimited DatastaleShanghai Simnova Biotechnology …Phase 1

CAR-NK-CD19 Cells (CAR-NK-CD19 Cells)

Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTStandard DatabasestaleYake Biotechnology Ltd.Phase 2

CAR-T cells targeting CD19 and CD22 (CAR-T cells targeting CD19 and CD22)

B-Cell Acute Lymphoblastic Leukemia, Adult · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTStandard DatabasestaleChildren's Hospital of Philadel…Phase 2

CART19 (CART19)

SLE; Systemic Lupus Erythematosus (SLE) · SLE

#SLE#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 30Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 1

CD19/CD20 CAR-T cell infusion (CD19/CD20 CAR-T cell infusion)

CAR · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 30Status Active
CGTLimited DatastaleAlex's Lemonade Stand FoundationPhase 1

GD2 CAR T cells (GD2 CAR T cells)

Neuroblastoma · GD2

#GD2#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 30Status Recruiting
CGTLimited DatastaleNational University Hospital, S…Phase 1

Interleukin, NK cells (Interleukin, NK cells)

Metastatic Nasopharyngeal · Metastatic Nasopharyngeal

#MetastaticNasopharyngeal#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 30Status Active
CGTStandard DatabasestaleBOE Technology Group Co., Ltd.Phase 2

NK cells + PD- (NK cells + PD-, NK cells + PD-(L)1 inhibitor + pemetrexed as first-line maintenance therapy)

NSCLC (Advanced Non-small Cell Lung Cancer); Colorectal Cancer · NSCLC (Advanced Non-small Cell Lung Canc

#NSCLCAdvancedNon-smallCellLungCa#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 30Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Preclinical

T cell injection targeting CD19 chimeric antigen receptor (T cell injection targeting CD19 chimeric antigen receptor)

Systemic Lupus Erythematosus; Idiopathic Inflammatory Myopathies · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTStandard DatabasestaleKara Yakhteh Tajhiz Azma CompanyPhase 2

anti-CD19 CAR T cell therapy (anti-CD19 CAR T cell therapy)

Relapse/Refractory B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 30Status Recruiting

7 / 59 pages

← PreviousNext →